(RTTNews) - Biopharmaceutical company Akebia Therapeutics, Inc. (AKBA) announced Thursday it has resubmitted its New Drug Application (NDA) to the U.S. Food...
(RTTNews) - Basilea Pharmaceutica Ltd announced the FDA has accepted for filing the New Drug Application for the antibiotic ceftobiprole. The FDA has set...
(RTTNews) - Liquidia Corporation (LQDA) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the company's amendment to the...
(RTTNews) - Phathom Pharmaceuticals, Inc. (PHAT), a biopharmaceutical company focused on gastrointestinal or GI diseases, announced Tuesday the submission of...
(RTTNews) - Takeda Pharmaceutical Co. Ltd. (TAK) announced Wednesday that the U.S. Food and Drug Administration has accepted for review its New Drug...
(RTTNews) - Biogen Inc. (BIIB) announced that the U.S. Food and Drug Administration has approved Tofidence (tocilizumab-bavi) intravenous formulation, a...
The Food and Drug Administration is now warning hospitals not to give probiotics to preterm infants, after a baby was killed by bacteria linked to a...
By Ernie Mundell HealthDay Reporter FRIDAY, Sept. 29, 2023 (HealthDay News) -- Faced with growing reports of inaccurate clinical lab tests, the U.S. Food and...
(RTTNews) - Apellis Pharmaceuticals, Inc. (APLS) announced the FDA has approved the EMPAVELI Injector. It is a single-use, on-body device designed to enhance...
By Cara Murez HealthDay Reporter THURSDAY, Sept. 28, 2023 (HealthDay News) An advisory panel to the U.S. Food and Drug Administration on Wednesday voted...
(RTTNews) - Takeda (TAK) said that the U.S. Food and Drug Administration has approved a subcutaneous or SC administration of Entyvio (vedolizumab) for...
(RTTNews) - The U.S. Food and Drug Administration granted de novo marketing authorization for Invitae's Common Hereditary Cancers Panel, an in vitro...
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA) said the FDA has granted Fast Track designation to development program investigating IDE161 for the treatment of...
(RTTNews) - Cabaletta Bio, Inc. (CABA), a clinical-stage biotechnology company focused on targeted cell therapies for patients with autoimmune diseases,...
The Food and Drug Administration on Tuesday declined to approve Neffy, an epinephrine nasal spray that offers a needle-free alternative for treating severe...
(RTTNews) - Hoth Therapeutics, Inc. (HOTH) announced the Pre-IND meeting previously requested for HT-KIT with the FDA has been granted to receive written...
(RTTNews) - Viatris Inc. (VTRS) and Ocuphire Pharma, Inc. (OCUP) announced the FDA has approved RYZUMVI 0.75% for the treatment of pharmacologically-induced...
Genetic testing that reveals potential cancer risks or other maladies with no regulatory oversight is among the targets of the agencys proposed review. The...
WASHINGTON (AP) Federal health advisers voted overwhelmingly against an experimental treatment for Lou Gehrigs disease at a Wednesday meeting prompted by...
In trading on Monday, shares of Idacorp Inc (Symbol: IDA) entered into oversold territory, changing hands as low as $90.28 per share. We define oversold...